Panakeia delivers rapid, cost-effective multi-omics molecular analysis directly from routine H&E-stained tissue images using proprietary AI technology. This platform provides essential biomarker information in minutes, significantly accelerating the timeline compared to traditional physical testing methods. The resulting data enhances both clinical diagnostics and pharmaceutical drug development pipelines.
Funding
$3.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional cancer diagnosis relies on multiple physical tests and complex molecular analysis, leading to extended turnaround times and increased costs. Extracting comprehensive biomarker information from tissue samples often requires days or weeks, delaying treatment decisions.
Solution
Panakeia offers an AI-driven multi-omics molecular analysis platform that extracts biomarker information directly from routine H&E-stained tissue images. The technology eliminates the need for multiple physical tests, providing comprehensive ‘omics’ molecular profiling of patient tissues significantly faster and cheaper than traditional methods. By applying advanced artificial intelligence to digitized pathology slides, Panakeia generates reliable results in minutes, enhancing clinical diagnostics and accelerating drug development. The platform enables clinicians and researchers to gain deeper insights into disease mechanisms and personalize treatment strategies more effectively.
Target Audience
The primary target audience includes hospitals, diagnostic labs, and research institutions involved in cancer diagnostics and drug development.
Features
- AI-powered analysis of H&E-stained tissue images for biomarker extraction
- Multi-omics molecular profiling directly from digitized pathology slides
- Rapid results in minutes, eliminating the need for multiple physical tests
- Comprehensive biomarker information for enhanced clinical diagnostics
- Technology applicable to both clinical diagnostics and drug development